These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 19343732)
21. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action. Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954 [TBL] [Abstract][Full Text] [Related]
22. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines. Chakrabarti R; Robles LD; Gibson J; Muroski M Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771 [TBL] [Abstract][Full Text] [Related]
23. Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells. Nadiminty N; Dutt S; Tepper C; Gao AC Prostate; 2010 Feb; 70(3):276-87. PubMed ID: 19827050 [TBL] [Abstract][Full Text] [Related]
24. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines. Eroğlu C; Seçme M; Bağcı G; Dodurga Y Tumour Biol; 2015 Dec; 36(12):9437-46. PubMed ID: 26124008 [TBL] [Abstract][Full Text] [Related]
25. PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells. Lemos AE; Ferreira LB; Batoreu NM; de Freitas PP; Bonamino MH; Gimba ER Tumour Biol; 2016 Aug; 37(8):11339-48. PubMed ID: 26960690 [TBL] [Abstract][Full Text] [Related]
26. [Effect of PC-1 gene expression on migration ability of prostate cancer cells]. Zhang H; Wan LC; Wang J; Zhou JG; Huang CF Ai Zheng; 2005 Sep; 24(9):1043-7. PubMed ID: 16159422 [TBL] [Abstract][Full Text] [Related]
27. Silencing of MEOX1 Gene Inhibits Proliferation and Promotes Apoptosis of LNCaP Cells in Prostate Cancer. Zhu ZY; Wang XL; Li DP Cancer Biother Radiopharm; 2019 Mar; 34(2):91-102. PubMed ID: 30543460 [TBL] [Abstract][Full Text] [Related]
28. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis. Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression. Lin X; Gu Y; Kapoor A; Wei F; Aziz T; Ojo D; Jiang Y; Bonert M; Shayegan B; Yang H; Al-Nedawi K; Major P; Tang D Neoplasia; 2017 Nov; 19(11):857-867. PubMed ID: 28930697 [TBL] [Abstract][Full Text] [Related]
30. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Leite KR; Sousa-Canavez JM; Reis ST; Tomiyama AH; Camara-Lopes LH; Sañudo A; Antunes AA; Srougi M Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056 [TBL] [Abstract][Full Text] [Related]
31. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342 [TBL] [Abstract][Full Text] [Related]
32. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663 [TBL] [Abstract][Full Text] [Related]
33. Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells. Tsubaki J; Hwa V; Twigg SM; Rosenfeld RG Endocrinology; 2002 May; 143(5):1778-88. PubMed ID: 11956160 [TBL] [Abstract][Full Text] [Related]
34. The determination of the potential anticancer effects of Coriandrum sativum in PC-3 and LNCaP prostate cancer cell lines. Elmas L; Secme M; Mammadov R; Fahrioglu U; Dodurga Y J Cell Biochem; 2019 Mar; 120(3):3506-3513. PubMed ID: 30417420 [TBL] [Abstract][Full Text] [Related]
35. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991 [TBL] [Abstract][Full Text] [Related]
36. Comparative intraosseal growth of human prostate cancer cell lines LNCaP and PC-3 in the nude mouse. Soos G; Jones RF; Haas GP; Wang CY Anticancer Res; 1997; 17(6D):4253-8. PubMed ID: 9494517 [TBL] [Abstract][Full Text] [Related]
37. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP. Fujinami K; Uemura H; Ishiguro H; Kubota Y Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554 [TBL] [Abstract][Full Text] [Related]
38. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells. Dalkin AC; Gilrain JT; Bradshaw D; Myers CE Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339 [TBL] [Abstract][Full Text] [Related]
39. In Silico Identification of Human miR 3654 and its Targets Revealed its Involvement in Prostate Cancer Progression. Saravanan S; Islam VI; Thirugnanasambantham K; Sekar D Microrna; 2016; 5(2):140-145. PubMed ID: 27297584 [TBL] [Abstract][Full Text] [Related]
40. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo. Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]